Broadcasts.com - "(Re)programming Stem Cells for Drug Development" (Vital Science)

Published: April 19, 2022, 8 a.m.

b'Mark Kotter, Founder and CEO of bit.bio, discusses technology to \\u201creprogram\\u201d stem cells.'